Update November 2, 2018- Amgen slashed the annual cost of this drug to $6,000.
March 8, 2017- Interviewed by Steven E. Greer, MD
We interviewed cardiologist William O’Neill, MD about his personal need for the cholesterol-lowering, large-molecule, antibody drug from Amgen, branded as Repatha. Despite the drug being extremely effective, insurance companies are more and more refusing to pay for it.